Ken Griffin’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.07M Buy
776,441
+326,779
+73% +$1.65M ﹤0.01% 5221
2025
Q4
$3.04M Buy
449,662
+312,503
+228% +$2.19M ﹤0.01% 5121
2025
Q3
$957K Sell
137,159
-315,513
-70% -$2.19M ﹤0.01% 7626
2025
Q2
$2.77M Buy
452,672
+6,662
+1% +$44.3K ﹤0.01% 5114
2025
Q1
$3.39M Buy
446,010
+178
+0% +$1.49K ﹤0.01% 4548
2024
Q4
$4.29M Sell
445,832
-141
-0% -$1.1K ﹤0.01% 4207
2024
Q3
$2.64M Buy
445,973
+405,648
+1,006% +$2.69M ﹤0.01% 5013
2024
Q2
$279K Buy
+40,325
New +$284K ﹤0.01% 9279
2024
Q1
Sell
-724
Closed -$5.82K 15131
2023
Q4
$6.35K Sell
724
-116,692
-99% -$854K ﹤0.01% 13358
2023
Q3
$856K Sell
117,416
-89,054
-43% -$663K ﹤0.01% 6901
2023
Q2
$1.36M Sell
206,470
-107,771
-34% -$549K ﹤0.01% 5845
2023
Q1
$1.07M Buy
314,241
+156,842
+100% +$607K ﹤0.01% 6624
2022
Q4
$438K Buy
157,399
+102,305
+186% +$306K ﹤0.01% 8527
2022
Q3
$158K Sell
55,094
-50,202
-48% -$178K ﹤0.01% 10654
2022
Q2
$365K Sell
105,296
-249,875
-70% -$978K ﹤0.01% 9364
2022
Q1
$1.67M Buy
355,171
+83,073
+31% +$406K ﹤0.01% 6491
2021
Q4
$1.64M Buy
272,098
+194,217
+249% +$1.35M ﹤0.01% 6684
2021
Q3
$472K Buy
77,881
+64,066
+464% +$722K ﹤0.01% 10012
2021
Q2
$172K Sell
13,815
-297,451
-96% -$3.22M ﹤0.01% 12346
2021
Q1
$3.21M Buy
311,266
+228,854
+278% +$2.21M ﹤0.01% 5274
2020
Q4
$748K Buy
+82,412
New +$593K ﹤0.01% 7388
2018
Q4
Sell
-124,566
Closed -$770K 9507
2018
Q3
$770K Buy
+124,566
New +$563K ﹤0.01% 5981
2018
Q1
Sell
-72,246
Closed -$841K 8576
2017
Q4
$911K Sell
72,246
-304,057
-81% -$3.71M ﹤0.01% 4780
2017
Q3
$4.47M Buy
+376,303
New +$5.58M ﹤0.01% 2424
2016
Q3
Sell
-119,664
Closed -$954K 7538
2016
Q2
$954K Buy
119,664
+55,512
+87% +$432K ﹤0.01% 3606
2016
Q1
$560K Buy
64,152
+57,189
+821% +$475K ﹤0.01% 4253
2015
Q4
$65K Buy
6,963
+1,524
+28% +$13.2K ﹤0.01% 7093
2015
Q3
$52K Sell
5,439
-92,733
-94% -$979K ﹤0.01% 7552
2015
Q2
$1.14M Sell
98,172
-78,802
-45% -$811K ﹤0.01% 3785
2015
Q1
$1.84M Sell
176,974
-12,006
-6% -$112K ﹤0.01% 3168
2014
Q4
$2.18M Buy
188,980
+101,218
+115% +$1,000K ﹤0.01% 2821
2014
Q3
$625K Sell
87,762
-24,734
-22% -$172K ﹤0.01% 4339
2014
Q2
$798K Buy
112,496
+75,159
+201% +$440K ﹤0.01% 3788
2014
Q1
$229K Sell
37,337
-44,386
-54% -$326K ﹤0.01% 5376
2013
Q4
$715K Buy
81,723
+53,512
+190% +$328K ﹤0.01% 3585
2013
Q3
$118K Buy
+28,211
New +$155K ﹤0.01% 5217

Other funds holding MDXG

Ken Griffin's MDXG Position: Q1 2026 in Review

Ken Griffin increased its MiMedx Group (MDXG) stake by 73% in Q1 2026, buying an estimated $1.65M and bringing the position to 776,441 shares worth $3.07M. The position accounts for ﹤0.01% of the portfolio, ranked #5221.

Ken Griffin first reported a position in MDXG in Q3 2013 and has held it in 36 quarters since. The position peaked at $4.47M in Q3 2017. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • Ken Griffin held 776,441 shares of MiMedx Group worth $3.07M as of Q1 2026.
  • Ken Griffin bought 326,779 MiMedx Group shares in Q1 2026, an estimated $1.65M.
  • MiMedx Group made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5221 holding.
  • Ken Griffin first reported a position in MiMedx Group in Q3 2013 and has held it in 36 quarters since.
  • Ken Griffin's MiMedx Group position peaked at $4.47M in Q3 2017.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.